http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S55143988-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9a4924d5a8264ec54b1c42580d1d539
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-36
filingDate 1979-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a76786ab71848455d489a6fd7555dd30
publicationDate 1980-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S55143988-A
titleOfInvention Preparation of thienodiazepin-2-one derivative containing novel diamine derivative and novel diazepin derivative
abstract PURPOSE: To prepare the title compound having tranquillizing activity, etc., economically, in high yield, from N-thiophene diamine through a novel diamine derivative and a 2-halogenomethyl-thienoazepin derivative. n CONSTITUTION: An N-thiophene diamine of formula I (R 1 , 2 are H, alkyl, halogen, etc.; R 3 is H, alkyl, lower alkoxy, etc.) is reacted with a compound of formula II (R 4 is H, halogen, NO 2 , etc.; when the bond between C and Z is double bond, Z is NH and X is lower alkoxyl, or Z is O and X is halogen, etc., and when the bond is triple bond, Z is N) to afford a diamine derivative of formula III (Y is NH or O), which is subjected to intramolecular cyclization to obtain a compound of formula IV (X 1 is Cl or Br). The substitution group X 1 of the compound IV is converted to various groups by conventional method to obtain novel thienodiazepin derivatives of formula V. The objective compound of formula VI can be prepared by treating the compound V with a proper oxidizing agent in the presence of an inert solvent. n COPYRIGHT: (C)1980,JPO&Japio
priorityDate 1979-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226563868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66708587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226825355
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57473307
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410725
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419475145
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID166734

Total number of triples: 21.